local_hospital

Fakultní nemocnice v Motole

Address
V Úvalu 84, 15006 Prague, Czechia

Oncology and Neoplasms Research

At Fakultní nemocnice v Motole, clinical trial activity in oncology focuses on advanced epithelial ovarian, fallopian tube, and peritoneal carcinoma. This work is centered on evaluating new treatment approaches to help improve disease control and patient outcomes in newly diagnosed advanced cancer.

  • Testing a new therapy added to standard chemotherapy for advanced gynecologic cancer
  • Assessing progression-free survival as a measure of treatment effectiveness

The research reflects a strong interest in improving care for ovarian cancer through better cancer treatment strategies and outcome assessment.

Nervous System Diseases and Epilepsy Studies

Clinical research in neurology at this site includes studies in focal epilepsy, with attention on adults who continue to have seizures despite current therapy. The trials are designed to examine whether a new treatment can better reduce seizure frequency and improve daily control of the condition.

  • Evaluating a potential new option for focal seizures
  • Measuring changes in seizure frequency to understand treatment benefit

This area of research supports efforts to improve treatment effectiveness for people living with epilepsy and ongoing seizure burden.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
2
IMPs

Activity Indicator

Last 6 months

1
Trials started
New activity detected vs previous period.
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_upGrowing+100%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
2
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 634 other sites in Czechia

description
Trial volume
2
Outperforms 44% of sites
public
Therapeutic diversity
2areas
Outperforms 63% of sites
groups
Sponsor diversity
2sponsors
Outperforms 50% of sites

Therapeutic Area Benchmark — Czechia

Select a therapeutic area to compare against other sites in Czechia.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Czechia

Market Share

Country: Czechia

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Fakultní nemocnice v Motole

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Efficacy and Safety of Vormatrigine in Adults with Focal Epilepsy Receiving Concomitant Antiseizure Medications: A Randomized, Double-Blind, Placebo-Controlled TrialPraxis Precision Medicines Inc.Phase IIINot Yet RecruitingMay 2026

IMP list

lock Showing 1 of 2 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Oregovomab1Unknown2021-05-262021-05-26

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.